Status:
RECRUITING
BPH Global Registry
Lead Sponsor:
Société Internationale d'Urologie
Conditions:
Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms
Eligibility:
MALE
18+ years
Brief Summary
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment o...
Detailed Description
Due to a growing and aging population, cases of benign prostatic hyperplasia (BPH) have been on a steady rise. Studies show that by age 80, 90% of men experience BPH. (Garraway, Lee, Collins, 1991) Th...
Eligibility Criteria
Inclusion Criteria:
- Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention
Exclusion Criteria:
- Non-symptomatic BPH
- No treatment prescribed for BPH
Key Trial Info
Start Date :
March 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT05543200
Start Date
March 13 2023
End Date
March 1 2027
Last Update
May 18 2025
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Keck Medicine of USC
Los Angeles, California, United States, 90089
2
Toronto Western Hospital, University Health Network
Toronto, Ontario, Canada
3
McGill University Health Centre
Montreal, Quebec, Canada
4
Hospital Dr. Juan Morey La Unión
La Unión, Chile